Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
about
Booster dose vaccination for preventing hepatitis BLessons learnt over two decades of vaccination against hepatitis B in ItalyHepatitis B and the need for a booster doseA Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface AntigenGender difference of alanine aminotransferase elevation may be associated with higher hemoglobin levels among male adolescents.Hepatitis B virus: where do we stand and what is the next step for eradication?Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.Twenty years of universal vaccination against hepatitis B in Italy: achievements and challenges.Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010.Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccinationHepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.Evaluation of hepatitis B surface antibody and specific gamma interferon response in health care workers after vaccination.Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional StudyThe one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.Impact of universal vaccination against hepatitis B: the italian model.Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme?Comparison of long-term immunogenicity (23 years) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children.Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea GovernorateHepatitis B immunization strategies: timing is everythingImmune persistence after hepatitis B vaccination in infancy - Fact or fancy?Immunopathology of hepatitis B virus infection.Potential role of killer immunoglobulin receptor genes among individuals vaccinated against hepatitis B virus in Lebanon.The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination.The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.Long-term persistence of immunity after vaccination of pre-adolescents with low doses of a recombinant hepatitis B vaccinePredictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan.Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children.Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.Vertical transmission of hepatitis B virus during pregnancy and delivery in Denmark.[Vaccination against hepatitis B: success and challenges].Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia.United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015.
P2860
Q24236587-A4D0B51A-FE50-4DBA-8D5A-D440A1614C23Q26770673-DB6EC66C-CCF5-4B4C-8739-644F6D138593Q28239937-C2B08364-E459-481B-806F-ECD36565FF9AQ30152118-991407DB-9C3E-42B4-AC22-06A2B2021D84Q33725657-5C9FF442-35E2-41D5-98EF-F9F30D647C25Q33958764-C34DC6FC-9B22-45C4-884D-25C1CD9DD830Q34067032-F82F81BC-24B4-4929-B608-0D5F45BF68C9Q34074115-D5FE9E81-9C7F-4D50-B0CF-302279B8000BQ34271615-F2E8A66C-9128-4BFC-B956-A8FAA8504C7BQ34290738-E98E4663-4F4A-4498-9B44-02E0B15A3053Q34425952-FD069E9F-4286-4151-A639-6D04765B88CFQ34581747-EB55AC1D-6592-4D90-8092-64F8CA7A04FAQ35148599-1753AA24-0C65-42CA-A25D-E98A10E1DD19Q35881684-EC5AE28B-0A80-43FF-B320-0BE466C2FD5BQ35886836-3FC5D6A9-BA35-43F8-BFA8-26FE55254988Q36220189-DC57787B-71B9-4B53-A162-ED391DC2DD98Q36246382-C7520D0E-E9B6-43F5-B694-02DFC9692670Q36552883-02C647E6-8A89-455B-9E84-1994A83E3972Q37006564-508653CC-76A0-4B31-BD96-E26676BF129EQ37052559-BEA89D43-4EF5-4142-A173-48B322532054Q37131019-A7FBA026-A231-4760-B0A5-D3FA8AD572B4Q37344233-1156D899-22F7-495C-AAE0-9570B1107531Q37345255-8EAC697C-BE5D-4710-8B97-BA425EFCC183Q37448838-F7181E2B-B094-405E-B291-3063A2040B93Q37514774-DF950ED1-A746-4094-8072-DC8D0DAF51E9Q37521932-9654DD1F-FC48-44F7-A023-802BDDE0E749Q37530082-AB141580-F331-476E-A45B-4308C5A225E4Q37605957-B43874FE-E2F5-40D7-B32D-FFD51D6618F2Q38036063-C981B0A1-8615-4E98-A7FA-1FB535D9A18EQ38969885-1F43D5B7-E896-41D8-836D-F467600140A5Q39633568-DA3F8F84-4D37-42A9-AAAD-0B7F9C8BD337Q39812218-7F24DA06-2AAF-4BD2-A4BA-410F9E52CF53Q40057020-0A2DD175-8BF4-43B0-B2FB-D908DBEB7633Q40333038-3F787B0E-B112-4CC6-8FD8-F35D23A18315Q40440788-80D4C503-236A-40FE-B4FF-3161312EB5F5Q40475167-1C40C891-9722-4FE7-AF83-0C35C155BA86Q40544414-A2A19E47-DE13-4164-A3B9-242F102BD261Q40545036-0D9D1095-735F-4E45-B747-2BDEBE1B5936Q40571829-DAD4C4D6-AC4F-4A6F-B579-7C7DD286B7AAQ40990518-12164446-5579-437D-AE22-731208BC301A
P2860
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Humoral and cellular immune re ...... s after neonatal immunization.
@en
Humoral and cellular immune re ...... s after neonatal immunization.
@nl
type
label
Humoral and cellular immune re ...... s after neonatal immunization.
@en
Humoral and cellular immune re ...... s after neonatal immunization.
@nl
prefLabel
Humoral and cellular immune re ...... s after neonatal immunization.
@en
Humoral and cellular immune re ...... s after neonatal immunization.
@nl
P2093
P2860
P50
P356
P1476
Humoral and cellular immune re ...... s after neonatal immunization.
@en
P2093
Hsu-Sung Kuo
Mei-Hwei Chang
P2860
P304
P356
10.1086/587695
P407
P50
P577
2008-05-01T00:00:00Z